Our objective is to prepare monoclonal antibodies which recognize the antigens expressed by normal or acute nonlymphocytic leukemic (ANL) progenitor cells. We will then use these antibodies to isolate and characterize normal progenitor subpopulations and determine if malignant progenitor cells can be separated from those capable of normal hematopoiesis. Our approach is based on our previous characterization of antigens present on normal myeloid colony forming cells and their precursors, including progenitors capable of establishing hematopoiesis in vivo. These antigenic markers were useful for distinguishing leukemic colony-forming cells from normal colony- forming cell precursors in some but not all patients with ANL. An important aspect of these studies was the use of a clonal marker to discern the malignant versus normal origin of the separated stem cell populations. In the period of this proposal we will 1) prepare monoclonal antibodies that recognize novel antigens on normal and malignant progenitor cells, and define the biochemical nature of these antigens. We will then 2) use these antibodies to isolate and characterize normal and malignant progenitors present in ANL specimens that express a clonal marker. This will include studies to detect premalignant progenitors, and with patients in remission, rare populations of clonally derived cells. Selective depletion of ANL progenitor cells or isolation of normal progenitors would provide a rational basis for monoclonal antibody treatment of ANL.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA039492-07
Application #
3178536
Study Section
Experimental Immunology Study Section (EI)
Project Start
1985-08-01
Project End
1993-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
7
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Behm, F G; Smith, F O; Raimondi, S C et al. (1996) Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements. Blood 87:1134-9
Smith, F O; Rauch, C; Williams, D E et al. (1996) The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q Blood 87:1123-33
Smith, F O; Raskind, W H; Fialkow, P J et al. (1995) Cellular biology of acute myelogenous leukemia. J Pediatr Hematol Oncol 17:113-22
Park, J R; Bernstein, I D; Hockenbery, D M (1995) Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood 86:868-76
Bigas, A; Martin, D I; Bernstein, I D (1995) Generation of hematopoietic colony-forming cells from embryonic stem cells: synergy between a soluble factor from NIH-3T3 cells and hematopoietic growth factors. Blood 85:3127-33
Milner, L A; Kopan, R; Martin, D I et al. (1994) A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors. Blood 83:2057-62
Ekert, H; Sievers, E L; Tan, A et al. (1994) GATA-1 is expressed in acute erythroblastic leukaemia. Br J Haematol 86:410-2
Smith, F O; Raskind, W H; Waldron, P et al. (1993) Clonal remission in childhood acute myeloid leukemia is an infrequent event. Leukemia 7:929-32
Brashem-Stein, C; Flowers, D A; Smith, F O et al. (1993) Ontogeny of hematopoietic stem cell development: reciprocal expression of CD33 and a novel molecule by maturing myeloid and erythroid progenitors. Blood 82:792-9
Rowley, S D; Brashem-Stein, C; Andrews, R et al. (1993) Hematopoietic precursors resistant to treatment with 4-hydroperoxycyclophosphamide: requirement for an interaction with marrow stroma in addition to hematopoietic growth factors for maximal generation of colony-forming activity. Blood 82:60-5

Showing the most recent 10 out of 29 publications